Advertisement
| latest research on aromatase inhibitors: Manual of Adult and Paediatric Medical Oncology S. Monfardini, K. Brunner, D. Crowther, S. Eckhardt, D. Olive, S. Tanneberger, A. Veronesi, J.M.A. Whitehouse, R. Wittes, 2012-12-06 It is a very special honour for me to be able to present this handbook of medical oncology, which under diverse headings and origins covers such a vast spectrum of experience. I be lieve the reader will be struck in particular by the impressive volume of information available, especially with regard to childhood tumours, which represent, today, an immense lab oratory of hope. It is in this very field that we oncologists have been able to obtain the most consoling results in recent years. I feel sure that all those who read these chapters will find that their oncological competence is enriched and also in a certain sense that their wish to contribute to progress in can cer research and treatment has been renewed. In conclusion, my most heartfelt congratulations go to the authors for the excellent job they have done, as well as my ad miration for having been able to concentrate so much pre cious and innovative information into so little space. Umberto Veronesi Preface Since 1976, the VICC has been holding chemotherapy courses in all parts of the world, excluding North America and Australia. The Manual of Cancer Chemotherapy, origi nally devised as a didactic tool to be used by course partici pants, expanded itself in the successive editions to a compre hensive, although schematic, textbook of medical oncology. |
| latest research on aromatase inhibitors: Latest Research on Breast Cancer - Molecular Insights, Diagnostic Advances and Therapeutic Innovations , 2025-05-28 Latest Research on Breast Cancer - Molecular Insights, Diagnostic Advances and Therapeutic Innovations brings together innovative and multidisciplinary contributions addressing one of the most complex and heterogeneous diseases in modern oncology. This volume presents a comprehensive overview of recent advances in breast cancer research, spanning from tumor biology and molecular heterogeneity to the development of diagnostic technologies and novel therapeutic strategies. The book includes state-of-the-art discussions on imaging modalities such as MRI, ultrasound, and artificial intelligence-based diagnostic tools, as well as in-depth analyses of molecular mechanisms, signaling pathways, drug resistance, and tumor microenvironmental interactions. Contributions also explore emerging strategies in drug delivery, biomarker discovery, gene expression profiling, and immunological insights into metastasis, including the role of the microbiota and immune cell interactions in the bone metastatic niche. By integrating basic science, translational research, and clinical applications, this volume provides valuable perspectives for researchers, clinicians, and health professionals working in oncology, molecular biology, immunology, and precision medicine. The book aims to foster interdisciplinary dialogue and promote the development of innovative approaches for improving diagnosis, treatment, and patient outcomes in breast cancer. Edited by Prof. Ana Carolina Monteiro and Prof. Lulu Wang, the volume reflects contributions from international experts and provides a timely reference for those committed to advancing breast cancer research and care. |
| latest research on aromatase inhibitors: Metronomic Chemotherapy Guido Bocci, Giulio Francia, 2016-09-22 This book analyzes all aspects of metronomic chemotherapy, a new approach involving low-dose, long-term, and frequently administered therapy that has preclinical and clinical activity in various tumors. After an opening section on the pharmacological bases of metronomic chemotherapy, including its antiangiogenic effects and impact on immunity, preclinical studies on various classes of drug are discussed. Clinical applications of metronomic chemotherapy in a wide variety of tumors are then addressed in detail, with description of the results of all published studies. The clinical pharmacology of metronomic chemotherapy is also considered in depth, encompassing pharmacokinetics, pharmacogenetics, pharmacoeconomics, and adverse drug reactions. The book closes by describing the role of this therapy in the veterinarian clinic. |
| latest research on aromatase inhibitors: Cancer in the Elderly Carrie P. Hunter, Karen A. Johnson, Hyman B. Muss, 2000-03-01 This book presents comprehensive assessment and up-to-date discussion of the epidemiology, prevention, and treatment of cancer in the elderly, highlighting the growing demands of the disease, its biology, individual susceptibility, the impact of state-of-the-art and emerging therapies on reducing morbidity, and decision making processes. Describ |
| latest research on aromatase inhibitors: Resistance to Aromatase Inhibitors in Breast Cancer Alexey Larionov, 2015-04-25 Aromatase Inhibitors (AIs) treat postmenopausal estrogen receptor positive tumours, which constitute the majority of breast cancer patients. This comprehensive volume brings together the current knowledge from different relevant areas, including molecular mechanisms and translational aspects of drug resistance in AIs. Topics covered include research, experimental , and clinical data specifically focused on AI resistance in breast cancer. The volume will include three sections. The first section covers general knowledge about aromatase inhibitors, including regulation of aromatase genes, and structure and function of aromatase protein. The second section provides the detailed mechanisms of resistance to AIs, while the third section explores prediction of resistance and potential strategies to overcome resistance. Breast cancer is the most common female cancer and AIs significantly improve treatments outcomes compatibly to previously used endocrine treatments. However 10-15% of post-operative patients develop a relapse during adjuvant treatment with AIs; about 25-50% of the patients do not respond to AIs in neo-adjuvant or metastatic setting, and the majority of metastatic patients who initially respond develop resistance within 3 years. There is an important need to understand these mechanisms of resistance in order to develop methods of preventing or overcoming the resistance to AIs, which will ensure a more successful outcome in treating breast cancer. |
| latest research on aromatase inhibitors: Trends in Breast Cancer Prevention Jose Russo, 2016-07-14 This volume, with contributions from the most recognized experts in preventive strategies in breast cancer, presents the accepted as well as the novel ideas that have been introduced for the prevention of breast cancer. There is no single preventive agent that can stop the incidence of breast cancer—the malignant disease most frequently diagnosed in women of all races and nationalities. Furthermore, its incidence around the globe is increasing in industrialized countries. The worldwide incidence of breast cancer has increased 30-40% since the 1970s, reaching an excess of 1,390,000 new cases and a mortality of more than 460,000 cases in 2015. Therefore, what is needed is the development of rational strategies for the prevention of this fatal disease. |
| latest research on aromatase inhibitors: Brain Aromatase, Estrogens, and Behavior Jacques Balthazart, Gregory Ball, 2013 This book concerns how estrogens are synthesized in the brain and their two modes of action on behavior: a slow process involving gene transcription and a faster action at the cell membrane. The significance of the regulation and distribution of the estrogen synthesizing enzyme aromatase in the brain is also highlighted. |
| latest research on aromatase inhibitors: Breast MR Imaging Christiane Kuhl, 2006 |
| latest research on aromatase inhibitors: Introduction to Basics of Pharmacology and Toxicology Abialbon Paul, Nishanthi Anandabaskar, Jayanthi Mathaiyan, Gerard Marshall Raj, 2021-03-13 This book explains the pharmacological relationships between the various systems in the human body. It offers a comprehensive overview of the pharmacology concerning the autonomic, central, and peripheral nervous systems. Presenting up-to-date information on chemical mediators and their significance, it highlights the therapeutic aspects of several diseases affecting the cardiovascular, renal, respiratory, gastrointestinal, endocrinal, and hematopoietic systems. The book also includes drug therapy for microbial and neoplastic diseases. It also comprises sections on immunopharmacology, dermatological, and ocular pharmacology providing valuable insights into these emerging and recent topics. Covering the diverse groups of drugs acting on different systems, the book reviews their actions, clinical uses, adverse effects, interactions, and subcellular mechanisms of action. It is divided into 11 parts, subdivided into several chapters that evaluate the basic pharmacological principles that govern the different types of body systems. This book is intended for academicians, researchers, and clinicians in industry and academic institutions in pharmaceutical, pharmacological sciences, pharmacy, medical sciences, physiology, neurosciences, biochemistry, molecular biology and other allied health sciences. |
| latest research on aromatase inhibitors: Davis's Drug Guide for Rehabilitation Professionals Charles D. Ciccone, 2013-03-21 A one-of-a-kind guide specifically for rehabilitation specialists! A leader in pharmacology and rehabilitation, Charles Ciccone, PT, PhD offers a concise, easy-to-access resource that delivers the drug information rehabilitation specialists need to know. Organized alphabetically by generic name, over 800 drug monographs offer the most up-to-date information on drug indications, therapeutic effects, potential adverse reactions, and much more! A list of implications for physical therapy at the end of each monograph helps you provide the best possible care for your patients. It’s the perfect companion to Pharmacology in Rehabilitation, 4th Edition! |
| latest research on aromatase inhibitors: Drug-Induced Liver Disease Neil Kaplowitz, 2002-10-16 Featuring more than 4100 references, Drug-Induced Liver Disease will be an invaluable reference for gastroenterologists, hepatologists, family physicians, internists, pathologists, pharmacists, pharmacologists, and clinical toxicologists, and graduate and medical school students in these disciplines. |
| latest research on aromatase inhibitors: The Breast K. I. Bland, Edward M. Copeland, 2009 Offering the most comprehensive, up-to-date information on the diagnosis and management of, and rehabilitation following, surgery for benign and malignant diseases of the breast, this surgical reference is now in a new edition available in both print and online for easy, convenient access to the absolute latest advances. |
| latest research on aromatase inhibitors: HER2-Positive Breast Cancer Sara Hurvitz, Kelly McCann, 2018-07-26 Get a quick, expert overview of clinically-focused topics and guidelines that are relevant to testing for HER2, which contributes to approximately 25% of breast cancers today. This concise resource by Drs. Sara Hurvitz, and Kelly McCann consolidates today's available information on this growing topic into one convenient resource, making it an ideal, easy-to-digest reference for practicing and trainee oncologists. - Covers the diagnosis, treatments and targeted therapies, and management of breast cancers that are HER2-positive. - Contains sections on background and testing, advanced disease, therapeutics, and toxicity considerations. - Includes a timely section on innovative future therapies. |
| latest research on aromatase inhibitors: Management of Cancer in the Older Patient E-Book Arash Naeim, David Reuben, Patricia Ganz, 2011-08-17 Management of Cancer in the Older Patient, by Drs. Arash Naeim, David Reuben, and Patricia Ganz, offers the help you need to effectively diagnose, refer, and manage cancer in geriatric patients. You’ll see how to provide effective cancer screening; refer your patients to the right oncologist; deal with comorbidities, frailties, and other complications; navigate end-of-life issues; and much more. A templated, user-friendly format makes it easy to find and apply the answers you need. See how to best manage geriatric cancer patients with help from leading specialists in both geriatrics and oncology Make informed decisions as to when to refer patients to specialists. Provide the supportive care your patients and their families need on issues such as such as mental health, pain, fatigue, nausea, insomnia. Be prepared to help cancer survivors navigate their after-treatment care including adjuvant therapy, side effects, second cancers, quality of life, and other concerns. Offer accurate guidance on ethical issues like competency, end of life, hospice, the role of the caregiver, and more. |
| latest research on aromatase inhibitors: Breast Cancer: New Insights for the Healthcare Professional: 2011 Edition , 2012-01-09 Breast Cancer: New Insights for the Healthcare Professional: 2011 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Breast Cancer. The editors have built Breast Cancer: New Insights for the Healthcare Professional: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Breast Cancer in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Breast Cancer: New Insights for the Healthcare Professional: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| latest research on aromatase inhibitors: Hepatotoxicity Hyman J. Zimmerman, 1978 Written by the foremost authority in the field, this volume is a comprehensive review of the multifaceted phenomenon of hepatotoxicity. Dr. Zimmerman examines the interface between chemicals and the liver; the latest research in experimental hepatotoxicology; the hepatotoxic risks of household, industrial, and environmental chemicals; and the adverse effects of drugs on the liver. This thoroughly revised, updated Second Edition features a greatly expanded section on the wide variety of drugs that can cause liver injury. For quick reference, an appendix lists these medications and their associated hepatic injuries. Also included are in-depth discussions of drug metabolism and factors affecting susceptibility to liver injury. |
| latest research on aromatase inhibitors: Breast Cancer: New Insights for the Healthcare Professional: 2012 Edition , 2012-12-10 Breast Cancer: New Insights for the Healthcare Professional / 2012 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Breast Cancer. The editors have built Breast Cancer: New Insights for the Healthcare Professional / 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Breast Cancer in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Breast Cancer: New Insights for the Healthcare Professional / 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| latest research on aromatase inhibitors: Consultative Hemostasis and Thrombosis E-Book Craig S. Kitchens, Barbara A Konkle, Craig M. Kessler, 2013-02-20 A unique clinical focus makes Consultative Hemostasis and Thrombosis, 3rd Edition your go-to guide for quick, practical answers on managing the full range of bleeding and clotting disorders. Emphasizing real-world problems and solutions, Dr. Craig S. Kitchens, Dr. Barbara A. Konkle, and Dr. Craig M. Kessler provide all the clinical guidance you need to make optimal decisions on behalf of your patients and promote the best possible outcomes. Consult this title on your favorite e-reader with intuitive search tools and adjustable font sizes. Elsevier eBooks provide instant portable access to your entire library, no matter what device you're using or where you're located. Efficiently look up concise descriptions of each condition, its associated symptoms, laboratory findings, diagnosis, differential diagnosis, and treatment. Get the latest information on hot topics such as Disseminated Intravascular Coagulation, Thrombophilia, Clinical and Laboratory Assessment and Management, Thrombotic -Thrombocytopenic Purpura, and Heparin-Induced Thrombocytopenia. Apply today’s newest therapies, including those that are quickly becoming standard in this fast-changing field. Meet the needs of specific patient groups with a new chapter on Bleeding and the Management of Hemorrhagic Disorders in Pregnancy and an extensively updated chapter on Thrombosis and Cancer. Zero in on key information with a new user-friendly design, and all-new full-color format, abundant laboratory protocols, and at-a-glance tables and charts throughout. |
| latest research on aromatase inhibitors: Breast Cancer William L. McGuire, 1981 This is the fourth book in a series dealing with breast cancer. Volumes 1-3 were concerned with treatment, experimental biology, and a number of varied timely topics. The present volume continues to review the breast cancer field in the broadest sense. The first chapter addresses the question of selecting appropriate chemotherapy for the patient. In the 1970s, great advances were seen in our ability to achieve objective tumor regression with empirical combina tions of chemotherapeutic agents. The next decade will focus on precise methods to select those agents likely to have the greatest benefit in individual patients. Livingston has provided us with a thorough review of the current state of the art. We have known for some time that steroid hormone receptor assays of considerable value to clinicians caring for patients with advanced disease. Osborne and colleagues now present considerable arguments that receptor assays are also useful in the setting of primary breast cancer for purposes of both prognosis and treatment strategy. A very important clinical problem which has received little attention in the research laboratory is benign breast disease. If one inquires about the medical therapy of this disorder in the United States, it is obvious that the majority of physicians would appreciate a better understanding of the pathophysiology which might lead to improved therapies. Mauvais-Jarvis and co-workers provide us with such an account from their wide experience. |
| latest research on aromatase inhibitors: Diagnosing and Treating Adult Cancers and Associated Impairments National Academies Of Sciences Engineeri, National Academies of Sciences Engineering and Medicine, Health And Medicine Division, Board On Health Care Services, Committee on Diagnosing and Treating Adult Cancers, 2021-11-10 Cancer is the second leading cause of death among adults in the United States after heart disease. However, improvements in cancer treatment and earlier detection are leading to growing numbers of cancer survivors. As the number of cancer survivors grows, there is increased interest in how cancer and its treatments may affect a person's ability to work, whether the person has maintained employment throughout the treatment or is returning to work at a previous, current, or new place of employment. Cancer-related impairments and resulting functional limitations may or may not lead to disability as defined by the U.S. Social Security Administration (SSA), however, adults surviving cancer who are unable to work because of cancer-related impairments and functional limitations may apply for disability benefits from SSA. At the request of SSA, Diagnosing and Treating Adult Cancers and Associated Impairments provides background information on breast cancer, lung cancer, and selected other cancers to assist SSA in its review of the listing of impairments for disability assessments. This report addresses several specific topics, including determining the latest standards of care as well as new technologies for understanding disease processes, treatment modalities, and the effect of cancer on a person's health and functioning, in order to inform SSA's evaluation of disability claims for adults with cancer. |
| latest research on aromatase inhibitors: Common Issues in Breast Cancer Survivors Gretchen G. Kimmick, Rebecca A. Shelby, Linda M. Sutton, 2021-08-23 This book provides a clinically useful resource for evaluation and management of the symptoms and issues that burden survivors of breast cancer. Improvements to breast cancer screening and treatment have resulted in more patients than ever before having been cured after local definitive and systemic therapies. Primary care providers and specialists must be increasingly familiar with the issues that breast cancer survivors routinely face. This is the first book to provide a single resource for common issues faced by breast cancer survivors from a truly multidisciplinary perspective; each chapter of this text is coauthored by at least one oncologist and one specialist outside the field of oncology in order to include the perspectives of relevant disciplines. User-friendly and clinically applicable to all specialties, individual chapters also include tables and figures that describe how best to conduct initial evaluation of the given symptom as well as an algorithm, where applicable, outlining the optimal management approach. Common Issues in Breast Cancer Survivors: A Practical Guide to Evaluation and Management empowers non-cancer specialists and practitioners who care for breast cancer survivors to address common issues that impact patient quality of life. |
| latest research on aromatase inhibitors: Osteoporosis Steven R. Cummings, Felicia Cosman, Sophie A. Jamal, 2002 Until recently considered an inevitable part of aging, osteoporosis is typically diagnosed only after a serious complication such as a fracture. It is now possible, however, to diagnose high-risk patients beforehand. Easily performed noninvasive tests estimate bone mass, and patients at risk can be treated with new drugs whose efficacy for fracture reduction has been proven in clinical trials. Osteoporosis: An Evidence-Based Guide to Prevention and Management, the newest volume in the acclaimed ACP Women's Health series, addresses every important facet of this common disease. The latest scientific evidence and the extensive clinical experience of the authors provide essential information on the origins and progress of osteoporosis. Treatment options are thoroughly reviewed. |
| latest research on aromatase inhibitors: Medicinal Chemistry of Anticancer Drugs Carmen Avendano, J. Carlos Menendez, 2015-04-28 Medicinal Chemistry of Anticancer Drugs, Second Edition, provides an updated treatment from the point of view of medicinal chemistry and drug design, focusing on the mechanism of action of antitumor drugs from the molecular level, and on the relationship between chemical structure and chemical and biochemical reactivity of antitumor agents. Antitumor chemotherapy is a very active field of research, and a huge amount of information on the topic is generated every year. Cytotoxic chemotherapy is gradually being supplemented by a new generation of drugs that recognize specific targets on the surface or inside cancer cells, and resistance to antitumor drugs continues to be investigated. While these therapies are in their infancy, they hold promise of more effective therapies with fewer side effects. Although many books are available that deal with clinical aspects of cancer chemotherapy, this book provides a sorely needed update from the point of view of medicinal chemistry and drug design. |
| latest research on aromatase inhibitors: Encyclopedia of Breast Cancer , 2010 |
| latest research on aromatase inhibitors: Normal at Any Cost Susan Cohen, Christine Cosgrove, 2009 Cohen and Cosgrove present a fascinating story of medical experimentation, parental love, and the extreme measures taken to make children fit within the normal height range. |
| latest research on aromatase inhibitors: Clinical Gynecology Eric J. Bieber, Joseph S. Sanfilippo, Ira R. Horowitz, Mahmood I. Shafi, 2015-04-23 Written with the busy practice in mind, this book delivers clinically focused, evidence-based gynecology guidance in a quick-reference format. It explores etiology, screening, tests, diagnosis, and treatment for a full range of gynecologic health issues. The coverage includes the full range of gynecologic malignancies, reproductive endocrinology and infertility, infectious diseases, urogynecologic problems, gynecologic concerns in children and adolescents, and surgical interventions including minimally invasive surgical procedures. Information is easy to find and absorb owing to the extensive use of full-color diagrams, algorithms, and illustrations. The new edition has been expanded to include aspects of gynecology important in international and resource-poor settings. |
| latest research on aromatase inhibitors: Adjuvant Therapy for Breast Cancer Monica Castiglione, Martine J. Piccart, 2009-07-11 Adjuvant treatment is administered prior to or as follow up to surgical procedures for breast cancer. Proven success in using medical therapies allowing for breast conserving procedures or reducing risk of occurrence. Although there has been much progress towards a cure, including the introduction of new targeted therapies, metastasizing cancer remains highly incurable. |
| latest research on aromatase inhibitors: Recent Advances in Polyphenol Research Fouad Daayf, Vincenzo Lattanzio, 2009-01-21 Polyphenols are the second most abundant class of substances in nature, and include tannins and flavonoids, many of which have extremely important antioxidant properties which have now been shown to have a key role in the prevention of cancer in humans. This important book covers polyphenol chemistry, biosynthesis and genetic manipulation, ecology and plant physiology, food and nutritional aspects and the effects of polyphenols on health. Included within the contents are cutting edge chapters on biotic and abiotic stress in plants, safety and toxicity in foods, functionality and nutraceutical benefits in nutrition, and aspects of pharmaceutical and cosmetic discovery and development. Sponsored by Groupe Polyphenols, this landmark book has been edited by Professor Fouad Daayf and Professor Vincenzo Lattanzio, who have drawn together an impressive list of internationally respected contributing authors, each providing a comprehensive review of the current situation regarding each important subject covered. Recent Advances in Polyphenol Research is an important publication which will be of great use to chemists, biochemists, plant scientists, pharmacognosists and pharmacologists, food scientists and nutritionists. Libraries in all universities and research establishments where these subjects are studied and taught should have copies of this book on their shelves. |
| latest research on aromatase inhibitors: A Comprehensive Guide to the Therapeutic Use of Aminoglutethimide Richard J. Santen, I. Craig Henderson, 1981 |
| latest research on aromatase inhibitors: Recent Progress and Perspectives in Neurosteroid Research Hubert Vaudry, Kiran K. Soma, Takayoshi Ubuka, Kazuyoshi Tsutsui, 2022-08-16 |
| latest research on aromatase inhibitors: Advances in Cytochrome P-450 Enzyme System Research and Application: 2011 Edition , 2012-01-09 Advances in Cytochrome P-450 Enzyme System Research and Application: 2011 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Cytochrome P-450 Enzyme System in a concise format. The editors have built Advances in Cytochrome P-450 Enzyme System Research and Application: 2011 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Cytochrome P-450 Enzyme System in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Advances in Cytochrome P-450 Enzyme System Research and Application: 2011 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| latest research on aromatase inhibitors: Testosterone Susan Nieschlag, Eberhard Nieschlag, Hermann M. Behre, 2012-12-06 New developments in testosterone therapy are summarized here by internationally renowned experts. They review both basic and clinical knowledge in fourteen chapters. The book begins with the biochemistry of testosterone, its biosynthesis, metabolism and mechanisms of action in target organs. Three chapters deal with specific aspects of testosterone action, namely its role in spermatogenesis, its psychotropic effects and its effects on bones. Syndromes caused by androgen resistance are described in order to highlight the importance of properly functioning enzymes and receptors in the target organs. Causes and symptoms of male hypogonadism, the major indication for testosterone treatment, are described. Five chapters are devoted to the pharmacology, pharmacokinetics and clinical uses and abuses of testosterone preparations. The new transdermal testosterone application is described in detail. Side effects of testosterone treatment are reviewed. The possible role of androgens in the development of prostatic hypertrophy and carcinoma is discussed extensively since this question is of major concern to the clinician. |
| latest research on aromatase inhibitors: Steroid Hydroxylases—Advances in Research and Application: 2012 Edition , 2012-12-26 Steroid Hydroxylases—Advances in Research and Application: 2012 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Steroid Hydroxylases. The editors have built Steroid Hydroxylases—Advances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Steroid Hydroxylases in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Steroid Hydroxylases—Advances in Research and Application: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| latest research on aromatase inhibitors: Probably Someday Cancer Kim Horner, 2019-02-15 After learning that she inherited a BRCA2 genetic mutation that put her at high risk for breast and ovarian cancer, Kim Horner’s doctors urged her to consider having a double mastectomy. But how do you decide whether to have a surgery to remove your breasts to reduce your risk for a disease you don’t have and may never get? Horner shares her struggle to answer that question in Probably Someday Cancer. The mother of a one-year-old boy, she wanted to do whatever would give her the best odds of being around for her son and protect her from breast cancer, which killed her grandmother and great-grandmother in their 40s. Which would give her the best chance at a long healthy life: a double mastectomy or frequent screenings to try to catch any cancer early? The answers weren’t that simple. Based on extensive research, interviews, and personal experience, Horner writes about how and why she ultimately opted for a double mastectomy—the same decision actress Angelina Jolie made for a similar genetic mutation—and the surprising diagnosis that followed. The book explores difficult truths that get overshadowed by upbeat messages about early detection and survivorship—the fact that screenings can miss cancers and that even early-stage breast cancers can spread and become fatal. Probably Someday Cancer is about the author’s efforts to push past her fear and anxiety. This book can help anyone facing hereditary risk of breast and ovarian cancer feel less alone and make informed decisions to protect their health and end the devastation that hereditary cancer has caused for generations in so many families. |
| latest research on aromatase inhibitors: Osteoporosis: New Insights for the Healthcare Professional: 2012 Edition , 2012-12-10 Osteoporosis: New Insights for the Healthcare Professional / 2012 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about Osteoporosis. The editors have built Osteoporosis: New Insights for the Healthcare Professional / 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Osteoporosis in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Osteoporosis: New Insights for the Healthcare Professional / 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| latest research on aromatase inhibitors: 17-Ketosteroids—Advances in Research and Application: 2012 Edition , 2012-12-26 17-Ketosteroids—Advances in Research and Application: 2012 Edition is a ScholarlyEditions™ eBook that delivers timely, authoritative, and comprehensive information about 17-Ketosteroids. The editors have built 17-Ketosteroids—Advances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about 17-Ketosteroids in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of 17-Ketosteroids—Advances in Research and Application: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| latest research on aromatase inhibitors: Antidiabetic Agents—Advances in Research and Application: 2012 Edition , 2012-12-26 Antidiabetic Agents—Advances in Research and Application: 2012 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Antidiabetic Agents in a concise format. The editors have built Antidiabetic Agents—Advances in Research and Application: 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Antidiabetic Agents in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Antidiabetic Agents—Advances in Research and Application: 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| latest research on aromatase inhibitors: Your Life in Your Hands Jane A. Plant, 2007 'Your Life in Your Hands' considers both breast and ovarian cancer. It puts forward the message that the disease can be prevented and effectively treated by simple diet and lifestyle modifications. This paperback edition includes case studies of both women and men following the Plant Programme. |
| latest research on aromatase inhibitors: Hot Flashes: New Insights for the Healthcare Professional: 2012 Edition , 2012-12-10 Hot Flashes: New Insights for the Healthcare Professional / 2012 Edition is a ScholarlyPaper™ that delivers timely, authoritative, and intensively focused information about Hot Flashes in a compact format. The editors have built Hot Flashes: New Insights for the Healthcare Professional / 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Hot Flashes in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Hot Flashes: New Insights for the Healthcare Professional / 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
| latest research on aromatase inhibitors: Vasculitis: New Insights for the Healthcare Professional: 2012 Edition , 2012-12-10 Vasculitis: New Insights for the Healthcare Professional / 2012 Edition is a ScholarlyBrief™ that delivers timely, authoritative, comprehensive, and specialized information about Vasculitis in a concise format. The editors have built Vasculitis: New Insights for the Healthcare Professional / 2012 Edition on the vast information databases of ScholarlyNews.™ You can expect the information about Vasculitis in this eBook to be deeper than what you can access anywhere else, as well as consistently reliable, authoritative, informed, and relevant. The content of Vasculitis: New Insights for the Healthcare Professional / 2012 Edition has been produced by the world’s leading scientists, engineers, analysts, research institutions, and companies. All of the content is from peer-reviewed sources, and all of it is written, assembled, and edited by the editors at ScholarlyEditions™ and available exclusively from us. You now have a source you can cite with authority, confidence, and credibility. More information is available at http://www.ScholarlyEditions.com/. |
Fox News - Breaking News Updates | Latest News Headlines
Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
Breaking News, Latest News and Videos | CNN
View the latest news and breaking news today for U.S., world, weather, entertainment, politics and health at CNN.com.
Associated Press News: Breaking News, Latest Headlines and …
Stay informed and read the latest news today from The Associated Press, the definitive source for independent journalism from every corner of the globe.
The New York Times - Breaking News, US News, World News …
Iran’s air defenses were diminished in rounds of conflict, giving Israel greater aerial freedom. ‘Life feels like it is on hold’: Some Iranians brace for a long fight. The push to do a deal on the...
NBC News - Breaking News & Top Stories - Latest World, US
Go to NBCNews.com for breaking news, videos, and the latest top stories in world news, business, politics, health and pop culture.
Yahoo News: Latest and Breaking News, Headlines, Live …
The latest news and headlines from Yahoo News. Get breaking news stories and in-depth coverage with videos and photos.
ABC News - Breaking News, Latest News and Videos
Trump has made a number of claims about the LA protests. Here is the context. ABC News’ Will Ganss was at the Tribeca Film Festival premiere of “Barbara Walters: Tell Me Everything,” a …
CBS News | Breaking news, top stories & today's latest headlines
Law enforcement officials are searching for 57-year-old Vance Luther Boelter in the shootings of two Minnesota politicians and their spouses early Saturday morning, sources told CBS News. …
MSN | Personalized News, Top Headlines, Live Updates and more
Your personalized and curated collection of the best in trusted news, weather, sports, money, travel, entertainment, gaming, and video content
Breaking News and Analysis on Today's Top Stories: Video
Get the latest top news stories and videos on msnbc.com. Read breaking headlines covering politics, culture, and more.
Fox News - Breaking News Updates | Latest News Headlines
Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.
Breaking News, Latest News and Videos | CNN
View the latest news and breaking news today for U.S., world, weather, entertainment, politics and health at CNN.com.
Associated Press News: Breaking News, Latest Headlines and …
Stay informed and read the latest news today from The Associated Press, the definitive source for independent journalism from every corner of the globe.
The New York Times - Breaking News, US News, World News and …
Iran’s air defenses were diminished in rounds of conflict, giving Israel greater aerial freedom. ‘Life feels like it is on hold’: Some Iranians brace for a long fight. The push to do a deal on the...
NBC News - Breaking News & Top Stories - Latest World, US
Go to NBCNews.com for breaking news, videos, and the latest top stories in world news, business, politics, health and pop culture.
Yahoo News: Latest and Breaking News, Headlines, Live Updates, …
The latest news and headlines from Yahoo News. Get breaking news stories and in-depth coverage with videos and photos.
ABC News - Breaking News, Latest News and Videos
Trump has made a number of claims about the LA protests. Here is the context. ABC News’ Will Ganss was at the Tribeca Film Festival premiere of “Barbara Walters: Tell Me Everything,” a new …
CBS News | Breaking news, top stories & today's latest headlines
Law enforcement officials are searching for 57-year-old Vance Luther Boelter in the shootings of two Minnesota politicians and their spouses early Saturday morning, sources told CBS News. …
MSN | Personalized News, Top Headlines, Live Updates and more
Your personalized and curated collection of the best in trusted news, weather, sports, money, travel, entertainment, gaming, and video content
Breaking News and Analysis on Today's Top Stories: Video
Get the latest top news stories and videos on msnbc.com. Read breaking headlines covering politics, culture, and more.
